Shareholder alert: pomerantz law firm investigates claims on behalf of revance therapeutics, inc. - rvnc

New york , oct. 9, 2024 /prnewswire/ -- pomerantz llp is investigating claims on behalf of investors of revance therapeutics, inc. ("revance" or the "company") (nasdaq: rvnc). such investors are advised to contact danielle peyton at newaction@pomlaw.com or 646-581-9980, ext.
RVNC Ratings Summary
RVNC Quant Ranking